This is a demo store. No orders will be fulfilled.

Atinumab (anti-NOGO) - Primary antibody, specific to RTN4, Human IgG4SP, INHIBITOR of Reticulon-4 inhibitor, INHIBITOR of Reticulon-4 inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG4SP
  • Conjugation: Unconjugated
In stock
Item Number
Ab183417
Grouped product items
SKU Size
Availability
Price Qty
Ab183417-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab183417-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$509.90
Ab183417-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,279.90
Ab183417-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,049.90

Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Atinumab (anti-NOGO) - Primary antibody, specific to RTN4, Human IgG4SP, INHIBITOR of Reticulon-4 inhibitor
Synonyms 1110020G17Rik antibody | AA407876 antibody | AA409940 antibody | AA960376 antibody | ASY antibody | C130026I10Rik antibody | Foocen antibody | Glut4 vesicle 20 kDa protein antibody | Human NogoA antibody | Kiaa0886 antibody | KIAA4153 antibody | MGC116054
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity RTN4
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Reticulon-4 inhibitor
Product Description

Atinumab (anti-NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI).
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG4SP
Light Chain Type kappa
SDS-PAGE 145 kDa
Purification Method Protein A purified
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 1226761-65-4

Associated Targets(Human)

RTN4 Tbio Reticulon-4 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Atinumab (anti-NOGO) (Ab183417) - Flow Cytometry
Flow Cytometry analysis of HeLa cells labelling NOGO (red) with Atinumab (anti-NOGO) (Ab183417) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Atinumab (anti-NOGO) (Ab183417) - Flow Cytometry
Flow Cytometry analysis of A549 cells labelling NOGO (red) with Atinumab (anti-NOGO) (Ab183417) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Atinumab (anti-NOGO) (Ab183417) - SEC
The purity of Atinumab (anti-NOGO) (Ab183417) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.